These are staggering numbers
Effects on classic cardiovascular risk factors CVOTs on GLP-1RAs Data from the major CVOTs ELIXA, SUSTAIN-6, EXSCEL, HARMONY, PIONEER 6, LEADER, REWIND, and AMPLITUDE-O [53, 54, 56, 59,60,61,62,63] support the overall safety of GLP-1RAs relative to major cardiovascular outcomes
Your provider should guide dosing based on your baseline oxidative stress markers and tolerance, not generic recommendations
While some individuals may experience semaglutide effects like tiredness or fatigue, others undergo treatment with few hiccups
They may also screen for factors such as thyroid disease, depression, sleep apnea, menopause-related changes, or medicines that can affect weight